The Michigan Institute for Clinical & Health Research (MICHR) is leading the way in building the field of translational science, with the intent of extending life and reducing the impact of illness and disability. MICHR is developing and demonstrating scientific and operational innovations in the translational process, shortening the time to develop and deliver new treatments, and then sharing these solutions nationally. We are proud to be part of the national NCATS CTSA Program, with more than 60 academic research institutes working together to improve the process of translational research to deliver more treatments to more patients more quickly.
There is no investment information
No recent news or press coverage available for MICHR (Michigan Institute for Clinical & Health Research).